KathrinMariaBerntMD

Pediatric Hematology & Oncology • Philadelphia, PA

Instructor in Pediatrics, Dana-Farber Cancer Institute

Join to view full profile

Dr. Bernt is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bernt's full profile

Already have an account?

Office
3401 Civic Center Blvd
Philadelphia, PA 19104
Phone+1 215-590-1000

Fax+1 215-590-3992

Education & Training

Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 2006 - 2009
University of WashingtonResidency, Pediatrics, 2003 - 2006
Humboldt University of Berlin - Charite Faculty of MedicineClass of 1998

Certifications & Licensure

PA State Medical License 2017 - 2024
CO State Medical License 2013 - 2017
MA State Medical License 2009 - 2012
WA State Medical License 2003 - 2004
American Board of Pediatrics Pediatric Hematology-Oncology

Publications & Presentations

PubMed

491 citations
Chromatin-modifying enzymes as modulators of reprogramming
Tamer T. Onder, Nergis Kara, Anne Cherry, Amit U. Sinha, Nan Zhu
Nature. 2012-03-29
272 citations
MLL-Rearranged Leukemias—An Update on Science and Clinical Approaches
Amanda Winters, Kathrin M. Bernt
Frontiers in Pediatrics. 2017-02-09
7 citations
Mesenchyme-specific loss of Dot1L histone methyltransferase leads to skeletal dysplasia phenotype in mice.
Pearl A. Sutter, Sangita Karki, Ilan Crawley, Vijender Singh, Kathrin M. Bernt
Bone. 2021-01-01

Abstracts/Posters

SWI/SNF Dysregulation through a Prion-like Domain Causes AMLClinically Relevant Abstract
Kathrin M. Bernt, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

Chromatin Structure in Development and Disease
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Continuing Conversations With the Speakers on Chromatin Structure in Development and Disease
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Press Mentions

Study May Widen Patient Pool That Benefits from EPZ-5676 Against Acute Myeloid LeukemiaMarch 1st, 2016
Epigenetic Pathway and New Drug Show Promise in Reversing a Hard-to-Treat Childhood CancerJuly 11th, 2011
American Cancer Society and St. Baldrick’s Foundation Award Additional $720,000 in Research Grants Focused on Advancing Childhood Cancer TreatmentsFebruary 17th, 2024

Grant Support

H3K79 Methylation In Hematopoietic Stem Cell Development And Mll-Rearranged LeukNational Heart, Lung, And Blood Institute2010–2011

Other Languages

Spanish, German